CN104876913B - Preparation method of 4,6-dimethyl-2-thiopyrimidine-1,2,3-triazole compound with antitumor activity - Google Patents

Preparation method of 4,6-dimethyl-2-thiopyrimidine-1,2,3-triazole compound with antitumor activity Download PDF

Info

Publication number
CN104876913B
CN104876913B CN201510248696.4A CN201510248696A CN104876913B CN 104876913 B CN104876913 B CN 104876913B CN 201510248696 A CN201510248696 A CN 201510248696A CN 104876913 B CN104876913 B CN 104876913B
Authority
CN
China
Prior art keywords
dimethyl
mercaptopyrimidine
compound
copper wire
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510248696.4A
Other languages
Chinese (zh)
Other versions
CN104876913A (en
Inventor
姜玉钦
何兴
赵亚茹
李兴丰
郭妞
薛载坤
王雪伟
李言言
徐桂清
李伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Normal University
Original Assignee
Henan Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Normal University filed Critical Henan Normal University
Priority to CN201510248696.4A priority Critical patent/CN104876913B/en
Publication of CN104876913A publication Critical patent/CN104876913A/en
Application granted granted Critical
Publication of CN104876913B publication Critical patent/CN104876913B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/54Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a preparation method of a 4,6-dimethyl-2-thiopyrimidine-1,2,3-triazole compound with antitumor activity, which belongs to the field of antitumor drug synthesis technologies. The key point of the technical scheme of the invention is as follows: the method is implemented by taking a 4,6-dimethyl-2-thiopyrimidine terminal alkyne compound and a nitrine compound as raw materials, taking a copper wire as a catalyst and taking a supercutical fluid as a reaction solvent through reacting in a supercritical reaction device, so that a 4,6-dimethyl-2-thiopyrimidine-1,2,3-triazole compound is obtained. According to the invention, a supercritical fluid technology is applied to the process of synthesizing 4,6-dimethyl-2-thiopyrimidine-1,2,3-triazole compounds, so that the application of the reaction solvent is reduced, and a chemical reaction is quicker, time-saving, green and environmentally friendly, and reduces the energy consumption; and the catalyst used in a 'click' step is a fine copper wire in an electric wire, so that when the catalyst is separated, the fine copper wire can be taken out only by using tweezers, therefore, the operate is extremely simple and the fine copper wire can be repeatedly used.

Description

There is the 4,6- dimethyl -2- mercaptopyrimidine -1,2,3- triazole of anti-tumor activity The preparation method of compound
Technical field
The invention belongs to the synthesis technical field of anti-tumor activity medicine is and in particular to a kind of have the 4 of anti-tumor activity, The preparation method of 6- dimethyl -2- mercaptopyrimidine -1,2,3- triazole compound.
Background technology
Pyrimidine is a class be made up of 2 nitrogen-atoms and 4 carbon atoms containing the hexa-member heterocycle gripping two keys altogether, pyrimidine ring 2,4,5,6 all can occur substitution reaction, generate corresponding substituted uracil compound.Although pyrimidine in nature not Exist, but pyrimidines are the critically important materials of a class in vital movement, be widely present in human body and biology is internal, such as In five kinds of bases of modal formation dna and rna in nucleic acid three kinds are the derivant of pyrimidine: cytosine, thymus pyrimidine And uracil.In pesticide and medicine, the compound containing pyrimidine ring also occupies critically important status.Pesticide containing pyrimidine heterocyclic removes Play an important role in parasite killing, sterilization and the big field of weeding three outer, also have extensive work at aspects such as plant growth regulations With, and the medicine containing pyrimidine heterocyclic is concentrated mainly on antiviral and anti-tumor aspect, such as 5-fluorouracil, imatinib etc..4, 6- dimethyl -2- mercaptopyrimidine is a kind of pyrimidine cyclics containing sulfydryl, have leukemia, antithyroid enlargement, The effects such as antifungal, antitumor and anti-tubercle bacillus growth, medically have potential application prospect, can serve as metal simultaneously Buffer agent or electroplating additive (chemistry and biological engineering, 2007,10:77-78).In addition it has been reported that mercaptopyrimidine is permissible Form monodentate or bidentate complex with many transition metal, and formed stable four-membered ring chelate or by n, s atom with Three metallic atoms form cluster complexes, and these metal complexs similarly have biological activity, can produce antibacterial, convulsion and Antitetanic effect (inorg. biochem., 1997,65 (3): 207-217).
Calendar year 2001, meldal and sharpless is independently found that copper catalysis azide end group acetylene compound Additive reaction (cuaac), this reaction has raw material and is easy to get, and operation is simple, mild condition, product yield high, three-dimensional selection Property good, the features such as product easy purification, post-reaction treatment and product separate simple and convenient.1,2,3- triazole group chemistry and Field of medicaments has highly important status, and many contains the compound of 1,2,3- triazole ring structures, gives birth to well because having Manage activity and be developed to various medicines.For example: beta-Lactam antibiotic Tazobactam Sodium, it is continue clavulanic acid, sulbactam two The third after planting inhibitor is applied to clinical beta-lactamase inhibitor.Additionally, the azepine that " click-reaction " generates afterwards Oxazolyl group has the stability of aromatic rings, is not easily decomposed, and can tolerate strong acid, highly basic, and can protect under multiple Redox Conditions Keep steady fixed (j. org. chem., 2003,68:5381-5383).
Although the rise of supercritical liquid extraction technique only tens of year, due to this technology superior function and Good application prospect, many scientific research personnel have carried out research extensively and profoundly, tentatively realize industrialization, become supercritical The most ripe in fluid technique, most widely used one kind.Critical fluids have the diffusibility of similar gas and the dissolving energy of liquid Power, has low-viscosity concurrently, the characteristic of low surface tension is so that supercritical fluid can quickly penetrate into the thing of micropore simultaneously Matter.Thus be accordingly used in extraction rate during extraction quicker and effective than liquid, especially solvability can be with temperature, pressure and polarity Change.Supercritical fluid mainly has as reaction medium: supercritical h2O and supercritical co2Chemical reaction as solvent.Research Supercritical fluid chemical reaction has become exploitation Green Chemistry project the most active, particularly supercritical co2.Supercritical co2 Great advantage be nontoxic, non-combustible and cheap etc..In the state of supercritical, property can change carbon dioxide, and it is close Degree is bordering on liquid, and viscosity is bordering on gas, and diffusion coefficient is 100 times of liquid, thus has surprising solvability.Supercritical two The critical temperature of carbonoxide is 31.26 DEG C, and critical pressure is 7.3mpa, workable, and super critical condition readily satisfies.To surpass Critical technology is applied to chemical sending out and answers, and reaction system material not only can be made to contact more abundant, effective collision increase, also more agree with The theme of " Green Chemistry ".
Content of the invention
Present invention solves the technical problem that there is provided a kind of process is simple, be swift in response and energy-conserving and environment-protective have anti-swollen The preparation method of the 4,6- dimethyl -2- mercaptopyrimidine -1,2,3- triazole compound of tumor activity.
The present invention is to solve above-mentioned technical problem to adopt the following technical scheme that, have 4, the 6- dimethyl of anti-tumor activity- 2- mercaptopyrimidine -1, the preparation method of 2,3- triazole compounds it is characterised in that: with 4,6- dimethyl -2- mercaptopyrimidine End group acetylene compoundAnd azido compoundFor raw material, with copper wire as catalyst, with Supercritical fluid is reaction dissolvent, reacts 4,6- dimethyl -2- mercaptopyrimidine -1 is obtained in supercritical reaction apparatus, 2,3- tri- Nitrogen azole compounds, its general structure is, wherein substituent group r is cl, ch3、no2, in br or f One or more, substituent group r be phenyl ring on ortho position, meta or para position.
Limit further, there are 4,6- dimethyl -2- mercaptopyrimidine -1 of anti-tumor activity, 2,3- triazole compounds Preparation method, concretely comprise the following steps: weigh 4,6- dimethyl -2- mercaptopyrimidine end group acetylene compound, azido compound and urge Agent copper wire is placed in supercritical reaction apparatus, reacts 0.5-2h in 60-80 DEG C, after completion of the reaction with dichloromethane by reactant System's dissolution from supercritical reaction apparatus, then takes out catalyst copper wire with tweezers, rotation removes solvent, and column chromatography purification obtains 4,6- Dimethyl -2- mercaptopyrimidine -1,2,3- triazole compound.
Limit further, described 4,6- dimethyl -2- mercaptopyrimidine end group compound is the potassium carbonate with acetone as solvent For acid binding agent, 4,6- dimethyl -2- mercaptopyrimidines and propargyl bromide are obtained for raw material reaction, wherein 4,6- dimethyl -2- sulfydryl The mol ratio of pyrimidine, propargyl bromide and acid binding agent potassium carbonate is 1:2.5:2.
Limit further, described 4,6- dimethyl -2- mercaptopyrimidine -1, the preparation process of 2,3- triazole compounds The mol ratio of middle 4,6- dimethyl -2- mercaptopyrimidine end group acetylene compound, azido compound and catalyst copper wire is 1:1-2: 0.11-2.18.
Limit further, described catalyst is the copper wire extracted out from copper cash.Described supercritical fluid is supercritical CO 2 fluid.
4,6- dimethyl -2- mercaptopyrimidine -1,2,3- triazole the chemical combination with anti-tumor activity of the present invention Concrete reaction equation in the preparation method of thing is:
.
The invention has the advantages that (1) is according to medicine principle of hybridization, will have leukemia, anti-antifungal, antitumor 4,6- dimethyl -2- mercaptopyrimidine and the 1,2,3- triazole ring link with anti-hiv virus, antitumor isoreactivity Deng effect Get up, play the effect such as good antitumor;(2) supercritical fluid technology is applied to synthesis 4,6- dimethyl -2- sulfydryl phonetic Pyridine -1, during 2,3- triazole compounds, not only reduces the use of reaction dissolvent, and makes chemical reaction more fast Speed, saving time, reducing energy consumption, environmental protection;(3) present invention catalyst used in " click " step is in electric wire Thin copper wire, only need to be taken out with tweezers in separating catalyst, and operation is extremely simple and capable of circulation is used for multiple times.
Specific embodiment
By the following examples the above of the present invention is described in further details, but this should not be interpreted as this The scope inventing above-mentioned theme is only limitted to below example, all belongs to this based on the technology that the above of the present invention is realized Bright scope.
Reaction equation in preparation process is:
Embodiment 1
By 178.25mg (1mmol) compound (), 154.51mg (1mmol) neighbour's azido chlorobenzene and be coiled into spring-like 7.0mg thin copper wire sequentially adds in supercritical reaction apparatus, sets t=60 DEG C, and carbon dioxide is charged to 5.0mpa and (after stable is 9.0mpa), react 2h, use the dissolution from reaction unit by reaction system of 5ml dichloromethane after completion of the reaction, then taken with tweezers Go out catalyst thin copper wire, rotation removes solvent, and chromatography over CC obtains compound 1 328.2mg, yield 98.91%.1h nmr (400 mhz, cdcl3):δ= 7.93 (s, 1h), 7.47 (m, 1h), 7.42 (m, 1h), 7.32 (m, 2h), 6.63 (s, 1h), 4.47 (s, 2h), 2.29 (s, 6h).
Embodiment 2
By azido chlorobenzene between 178.25mg (1mmol) compound (), 184.28mg (1.2mmol) and be coiled into spring-like 22.7mg thin copper wire sequentially add in supercritical reaction apparatus, set t=70 DEG C, carbon dioxide is charged to 4.5mpa (after stable For 8.9mpa), react 1.5h, use the dissolution from reaction unit by reaction system of 5ml dichloromethane after completion of the reaction, then use tweezer Son takes out catalyst thin copper wire, and rotation removes solvent, and chromatography over CC obtains compound 2 329.5mg, yield 99.30%.1h nmr (400 mhz, cdcl3):δ= 7.97 (s, 1h), 7.74 (s, 1h), 7.60 (d, 1h), 7.44 (t, 1h), 7.39 (d, 1h), 6.75 (s, 1h), 4.58 (s, 2h), 2.43 (s, 6h).
Embodiment 3
178.25mg (1mmol) compound (), 266.01mg (2mmol) to azido toluene and are coiled into spring-like 110.8mg thin copper wire sequentially adds in supercritical reaction apparatus, sets t=80 DEG C, and carbon dioxide is charged to 4.0mpa and (after stable is 11.9mpa), react 1.5h, use the dissolution from reaction unit by reaction system of 5ml dichloromethane after completion of the reaction, then use tweezer Son takes out catalyst thin copper wire, and rotation removes solvent, and chromatography over CC obtains compound 3 309.2mg, yield 99.42%.1h nmr (400 mhz, cdcl3):δ= 7.93 (s, 1h), 7.56 (d, 2h), 7.29 (d, 2h), 6.74 (s, 1h), 4.59 (s, 2h), 2.44 (d, 9h).
Embodiment 4
By 178.25mg (1mmol) compound (), 266.01mg (2mmol) neighbour's azido toluene and be coiled into spring-like 67.8mg thin copper wire sequentially adds in supercritical reaction apparatus, sets t=70 DEG C, and carbon dioxide is charged to 5.0mpa and (after stable is 8.5mpa), react 0.5h, use the dissolution from reaction unit by reaction system of 5ml dichloromethane after completion of the reaction, then use tweezers Take out catalyst thin copper wire, rotation removes solvent, and chromatography over CC obtains compound 4 308.3mg, yield 99.13%.1h nmr (400 mhz, cdcl3):δ=7.67 (s, 1h), 7.27 (t, 1h), 7.23 (d, 1h), 7.19 (d, 2h), 6.64 (s, 1h), 4.49 (s, 2h), 2.30 (s, 6h), 2.07 (s, 3h).
Embodiment 5
By 178.25mg (1mmol) compound (), 164.01mg (1mmol) neighbour's azido Nitrobenzol and be coiled into spring-like 10.8mg thin copper wire sequentially add in supercritical reaction apparatus, set t=70 DEG C, carbon dioxide is charged to 5.0mpa (after stable For 8.8mpa), react 0.5h, use the dissolution from reaction unit by reaction system of 5ml dichloromethane after completion of the reaction, then use tweezer Son takes out catalyst thin copper wire, and rotation removes solvent, and chromatography over CC obtains compound 5 336.7mg, yield 98.34%.1h nmr (400 mhz, cdcl3):δ= 8.05 (t, 1h), 7.84 (s, 1h), 7.80 (m, 1h), 7.78 (m, 2h), 6.75 (s, 1h), 4.59 (s, 2h), 2.44 (s, 6h).
Embodiment 6
178.25mg (1mmol) compound (), 164.01mg (1mmol) to azido Nitrobenzol and are coiled into spring-like 75.6mg thin copper wire sequentially add in supercritical reaction apparatus, set t=70 DEG C, carbon dioxide is charged to 5.0mpa (after stable For 8.3mpa), react 0.5h, use the dissolution from reaction unit by reaction system of 5ml dichloromethane after completion of the reaction, then use tweezer Son takes out catalyst thin copper wire, and rotation removes solvent, and chromatography over CC obtains compound 6 338.3mg, yield 98.81%.1h nmr (400 mhz, cdcl3):δ= 8.39 (d, 2h), 8.10 (s, 1h), 7.94 (d, 2h), 6.76 (s, 2h), 4.59 (s, 2h), 2.43 (s, 6h).
Embodiment 7
By azido Nitrobenzol between 178.25mg (1mmol) compound (), 164.01mg (1mmol) and be coiled into spring-like 8.3mg thin copper wire sequentially add in supercritical reaction apparatus, set t=70 DEG C, carbon dioxide is charged to 5.0mpa and (after stable is 9.8mpa), react 0.5h, use the dissolution from reaction unit by reaction system of 5ml dichloromethane after completion of the reaction, then use tweezers Take out catalyst thin copper wire, rotation removes solvent, and chromatography over CC obtains compound 7 335.8mg, yield 98.08%.1h nmr (400 mhz, cdcl3):δ= 8.54 (s, 1h), 8.28 (d, 1h), 8.15 (d, 1h), 8.10 (s, 1h), 7.74 (t, 1h), 6.76 (s, 1h), 4.60 (s, 2h), 2.44 (s, 6h).
Embodiment 8
178.25mg (1mmol) compound (), 237.60mg (1.2mmol) to azido bromobenzene and are coiled into spring-like 140.0mg thin copper wire sequentially add in supercritical reaction apparatus, set t=70 DEG C, carbon dioxide is charged to 5.0mpa (after stable For 10.3mpa), react 0.5h, after completion of the reaction use 5ml dichloromethane by reaction system dissolution from reaction unit, Ran Houyong Tweezers take out catalyst thin copper wire, and rotation removes solvent, and chromatography over CC obtains compound 8 374.8mg, yield 99.61%.1h nmr (400 mhz, cdcl3):δ= 7.59 (s, 1h), 7.58 (t, 4h), 6.72 (s, 1h), 4.55 (s, 2h), 2.40 (s, 6h).
Embodiment 9
By 178.25mg (1mmol) compound (), 164.53mg (1.2mmol) neighbour's azido fluorobenzene and be coiled into spring-like 126.7mg thin copper wire sequentially add in supercritical reaction apparatus, set t=70 DEG C, carbon dioxide is charged to 5.0mpa (after stable For 10.0mpa), react 1.0h, after completion of the reaction use 5ml dichloromethane by reaction system dissolution from reaction unit, Ran Houyong Tweezers take out catalyst thin copper wire, and rotation removes solvent, and chromatography over CC obtains compound 9 314.1mg, yield 99.60%.1h nmr (400 mhz, cdcl3):δ= 8.12 (d, 1h), 7.97 (t, 1h), 7.41 (q, 1h), 7.28 (q, 2h), 6.73 (s, 1h), 4.58 (s, 2h), 2.43 (s, 6h).
Embodiment 10
By 178.25mg (1mmol) compound (), 161.10mg (1.2mmol) 2,6- dimethyl -4- azido toluene Sequentially add in supercritical reaction apparatus with the 125.1mg thin copper wire being coiled into spring-like, set t=80 DEG C, carbon dioxide is charged to 5.0mpa (being 11.1mpa after stable), reacts 2.0h, uses 5ml dichloromethane by reaction system from reaction unit after completion of the reaction Middle dissolution, then takes out catalyst thin copper wire with tweezers, rotation removes solvent, and chromatography over CC obtains compound 10 337.5mg, yield 99.56%.1h nmr (400 mhz, cdcl3):δ=7.55 (s, 1h), 6.96 (s, 2h), 6.72 (s, 1h), 4.60 (s, 2h), 2.40 (s, 6h), 2.33 (s, 3h), 1.91 (s, 6h).
Embodiment 11
By 178.25mg (1mmol) compound (), 142.80mg (1.2mmol) aziminobenzene be coiled into spring-like 110.6mg thin copper wire sequentially adds in supercritical reaction apparatus, sets t=70 DEG C, and carbon dioxide is charged to 5.0mpa and (after stable is 10.9mpa), react 2.0h, use the dissolution from reaction unit by product of 5ml dichloromethane after completion of the reaction, then taken with tweezers Go out catalyst thin copper wire, rotation removes solvent, and chromatography over CC obtains compound 11 296.1mg, yield 99.57%.1h nmr (400 mhz, cdcl3):δ= 7.97 (s, 1h), 7.67 (d, 2h), 7.48 (t, 2h), 7.41 (t, 1h), 6.73 (s, 1h), 4.58 (s, 2h), 2.41 (s, 6h).
Embodiment 12
By 178.25mg (1mmol) compound (), 213.78mg (1.2mmol) 2- nitro -6- azido toluene and around The 40.3mg thin copper wire becoming spring-like sequentially adds in supercritical reaction apparatus, sets t=70 DEG C, carbon dioxide is charged to 5.0mpa (being 9.0mpa after stable), reacts 1.5h, uses the dissolution from reaction unit by product of 5ml dichloromethane after completion of the reaction, then Take out catalyst thin copper wire with tweezers, rotation removes solvent, and chromatography over CC obtains compound 12 350.7mg, yield 98.40%.1h nmr (400 mhz, cdcl3):δ= 8.02 (d, 1h), 7.76 (s, 1h), 7.61 (d, 1h), 7.51 (t, 1h), 6.75 (s, 1h), 4.60 (s, 2h), 2.42 (s, 6h), 2.25 (s, 3h).
Embodiment 13
Biological activity determination
Take the centrifuge tube after 12 1.5ml sterilizings, numbering 1-12 respectively, 4, the 6- diformazan of corresponding 12 kinds of embodiments synthesis Base -2- mercaptopyrimidine -1,2,3- triazole compounds, it is made into 10mg/ml solution with dmso, separately take the centrifuge tube after a sterilizing Dmso is only added to make blank, it is standby that vibration is placed in 4 DEG C of refrigerators after mixing.With dmem culture fluid, ehrlich ascites cell is diluted to 3×106Individual/ml.Use 96 well culture plates, every hole adds states cell culture fluid 0.2ml.By 12 kinds of 4,6- bis- synthesized by the present invention Methyl -2- mercaptopyrimidine -1,2,3- triazole compounds and 5-fluorouracil add to every hole 20ml in above-mentioned culture fluid respectively, 5-fluorouracil compares, and anti tumor activity in vitro test data see table:
Embodiment 14
Biological activity determination
Take the centrifuge tube after 12 1.5ml sterilizings, numbering 1-12 respectively, 4, the 6- diformazan of corresponding 12 kinds of embodiments synthesis Base -2- mercaptopyrimidine -1,2,3- triazole compounds, it is made into 10mg/ml solution with dmso, separately take the centrifuge tube after a sterilizing Dmso is only added to make blank, it is standby that vibration is placed in 4 DEG C of refrigerators after mixing.With rpmi-1640 culture fluid by hepatoma carcinoma cell bel- 7402 are diluted to 1 × 105Individual/ml.Use 96 well culture plates, every hole adds states cell culture fluid 0.2ml.By synthesized by the present invention 12 kinds of 4,6- dimethyl -2- mercaptopyrimidine -1,2,3- triazole compounds and 5-fluorouracil add to above-mentioned culture respectively Every hole 20ml in liquid, 5-fluorouracil compares, and anti tumor activity in vitro test data see table:
Embodiment above describes ultimate principle, principal character and the advantage of the present invention, the technical staff of the industry should Understand, the present invention is not restricted to the described embodiments, the simply explanation present invention's described in above-described embodiment and description is former Reason, under the scope without departing from the principle of the invention, the present invention also has various changes and modifications, and these changes and improvements each fall within In the scope of protection of the invention.

Claims (5)

1. there is 4,6- dimethyl -2- mercaptopyrimidine -1 of anti-tumor activity, the preparation method of 2,3- triazole compounds, its It is characterised by: with 4,6- dimethyl -2- mercaptopyrimidine end group acetylene compoundAnd azido compoundFor raw material, with copper wire as catalyst, with supercritical carbon dioxide fluid as reaction dissolvent, in supercritical reaction React in device and 4,6- dimethyl -2- mercaptopyrimidine -1,2,3- triazole compounds are obtained, its general structure is, wherein substituent group r is cl, ch3、no2, one or more of br or f, substituent group r is benzene Ortho position on ring, meta or para position.
2. the 4,6- dimethyl -2- mercaptopyrimidine -1,2,3- triazole with anti-tumor activity according to claim 1 The preparation method of compound is it is characterised in that concretely comprise the following steps: weighs 4,6- dimethyl -2- mercaptopyrimidine end group acetylenic chemical combination Thing, azido compound and catalyst copper wire are placed in supercritical reaction apparatus, react 0.5-2h in 60-80 DEG C, after completion of the reaction With dichloromethane dissolution from supercritical reaction apparatus by reaction system, then take out catalyst copper wire with tweezers, rotation removes solvent, Column chromatography purification obtains 4,6- dimethyl -2- mercaptopyrimidine -1,2,3- triazole compound.
3. 4,6- dimethyl -2- mercaptopyrimidine -1,2,3- three nitrogen with anti-tumor activity according to claim 1 and 2 The preparation method of azole compounds it is characterised in that: described 4,6- dimethyl -2- mercaptopyrimidine end group acetylene compound be with Acetone is solvent, and potassium carbonate is acid binding agent, and 4,6- dimethyl -2- mercaptopyrimidines and propargyl bromide are that raw material reaction is prepared, wherein The mol ratio of 4,6- dimethyl -2- mercaptopyrimidine, propargyl bromide and acid binding agent potassium carbonate is 1:2.5:2.
4. the 4,6- dimethyl -2- mercaptopyrimidine -1,2,3- triazole with anti-tumor activity according to claim 1 The preparation method of compound it is characterised in that: described 4,6- dimethyl -2- mercaptopyrimidine -1,2,3- triazole compounds Preparation process in 4,6- dimethyl -2- mercaptopyrimidine end group acetylene compound, azido compound and catalyst copper wire mole Than for 1:1-2:0.11-2.18.
5. the 4,6- dimethyl -2- mercaptopyrimidine -1,2,3- triazole with anti-tumor activity according to claim 1 The preparation method of compound it is characterised in that: described catalyst is the copper wire extracted out from copper cash.
CN201510248696.4A 2015-05-18 2015-05-18 Preparation method of 4,6-dimethyl-2-thiopyrimidine-1,2,3-triazole compound with antitumor activity Expired - Fee Related CN104876913B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510248696.4A CN104876913B (en) 2015-05-18 2015-05-18 Preparation method of 4,6-dimethyl-2-thiopyrimidine-1,2,3-triazole compound with antitumor activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510248696.4A CN104876913B (en) 2015-05-18 2015-05-18 Preparation method of 4,6-dimethyl-2-thiopyrimidine-1,2,3-triazole compound with antitumor activity

Publications (2)

Publication Number Publication Date
CN104876913A CN104876913A (en) 2015-09-02
CN104876913B true CN104876913B (en) 2017-01-25

Family

ID=53944625

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510248696.4A Expired - Fee Related CN104876913B (en) 2015-05-18 2015-05-18 Preparation method of 4,6-dimethyl-2-thiopyrimidine-1,2,3-triazole compound with antitumor activity

Country Status (1)

Country Link
CN (1) CN104876913B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109608408A (en) * 2018-12-25 2019-04-12 河南师范大学 The preparation method of Paeonol Schiff link 1,2,3- triazole compound with anti-tumor activity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103059003A (en) * 2013-01-08 2013-04-24 河南师范大学 Benzimidazole-1,2,3-triazole compound having antifungal activity, and its preparation method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103059003A (en) * 2013-01-08 2013-04-24 河南师范大学 Benzimidazole-1,2,3-triazole compound having antifungal activity, and its preparation method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Copper on chitosan:a recyclable heterogeneous catalyst for azide-alkyne cycloaddition reactions in water;R.B.Nasir Baig et al.;《Green Chem.》;20131231;第15卷;1839-1843 *
Copper(II)-Promoted Regioselective Synthesis of 1,4-Disubstituted 1,2,3-Triazoles in Water;K.Rajender Reddy et al.;《Synlett》;20060221;957-959 *
苯并咪唑炔丙基硫醚的绿色合成;郑文涛等;《河南师范大学学报(自然科学版)》;20130731;第41卷(第4期);106-108 *

Also Published As

Publication number Publication date
CN104876913A (en) 2015-09-02

Similar Documents

Publication Publication Date Title
He et al. Efficient synthesis of tertiary α-hydroxy ketones through CO 2-promoted regioselective hydration of propargylic alcohols
Gečiauskaitė et al. Main group mechanochemistry
CN108047107B (en) The preparation method of diphenyl disenenide ether compound
CN111440176A (en) Metal complex promoted synthesis method of Reidesciclovir intermediate
CN108976170B (en) 5-trifluoromethyl-4H-imidazoline-4-ketone derivative and synthetic method thereof
Zhong et al. Copper-catalyzed synthesis of aryl and alkyl trifluoromethyl sulfides using CF3SiMe3 and Na2S2O3 as–SCF3 source
Liu et al. Silver-mediated radical phosphorylation/cyclization of N-allylbenzamides to access phosphoryl-substituted dihydroisoquinolones
CN104262213A (en) Method for synthesizing alpha-aryl-beta-sulfonyl amide
Mo et al. Radical-induced denitration of N-(p-nitrophenyl) propiolamides coupled with dearomatization: access to phosphonylated/trifluoromethylated azaspiro [4.5]-trienones
Dou et al. Two inorganic–organic hybrid silver-polyoxometalates as reusable catalysts for one-pot synthesis of propargylamines via a three-component coupling reaction at room temperature
CN104876913B (en) Preparation method of 4,6-dimethyl-2-thiopyrimidine-1,2,3-triazole compound with antitumor activity
CN102260200B (en) Method for synthesizing phenylsulfone compounds
Tang et al. p-Toluenesulfonic acid catalysed fluorination of α-branched ketones for the construction of fluorinated quaternary carbon centres
CN107011275A (en) A kind of synthetic method of 1,4,5 3 substitution, 1,2,3 triazole compounds
CN109705050B (en) Method for synthesizing 4-sulfenyl isoxazole
CN104086488B (en) A kind of synthetic method of 2,4,6-trisubstituted pyrimidine compounds
CN110845466A (en) Oxacyclononadiene derivative, pharmaceutical composition thereof, preparation method and application thereof
CN106117154B (en) A kind of neighbour's aryloxy group -1,4- diaryl -1,2,3- triazole derivatives and its preparation method and application
Matsuo et al. Silica-catalyzed carboxylative cyclization of propargylic amines with CO2
CN106117266B (en) A kind of preparation method of S aryl or alkyl thio-phosphonate class compound
Jo et al. Understanding Six-Membered NHC-Copper (I) Allylic Borylation Selectivity by Comparison with other Catalysts and Different Substrates
CN111004145B (en) Chiral optical amide substituted alpha, beta-diamino acid derivative and preparation method and application thereof
Cheng et al. Synthesis and catalytic activity of N-heterocyclic carbene metal carbonyl complexes based on 1-[2-(pyrazol-1-yl) phenyl] imidazole
CN102180755A (en) Synthesis method of azide compounds
PT104884A (en) COMPLEX OF COPPER (II) WITH LIGANDS 2,4-ETOXY-1,3,5-TRIAZAPENTADIENETO AND ITS APPLICATION AND THE 2,4-METOXI ANALOGUE AS CATALYSTS FOR PEROXIDATIVE, MICROWAVE-ASSISTED AND NO SOLVENT-ADDED OXIDATION OF ALCOHOLS SECONDARY TO CETONAS.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170125

Termination date: 20200518

CF01 Termination of patent right due to non-payment of annual fee